Effects of Disulfiram on Choice Behavior in a Rodent Gambling Task: Association with Catecholamine Levels

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2017 Nov 1

PMID 29085979

Citations 7

Authors

Patricia Di Ciano

Daniel F Manvich

Abhiram Pushparaj

Andrew Gappasov

Ellen J Hess

David Weinshenker

Bernard Le Foll

Affiliations

Soon will be listed here.

Abstract

Rationale: Gambling disorder is a growing societal concern, as recognized by its recent classification as an addictive disorder in the DSM-5. Case reports have shown that disulfiram reduces gambling-related behavior in humans.

Objectives: The purpose of the present study was to determine whether disulfiram affects performance on a rat gambling task, a rodent version of the Iowa gambling task in humans, and whether any changes were associated with alterations in dopamine and/or norepinephrine levels.

Methods: Rats were administered disulfiram prior to testing on the rat gambling task or prior to analysis of dopamine or norepinephrine levels in brain homogenates. Rats in the behavioral task were divided into two subgroups (optimal vs suboptimal) based on their baseline levels of performance in the rat gambling task. Rats in the optimal group chose the advantageous strategy more, and rats in the suboptimal group (a parallel to problem gambling) chose the disadvantageous strategy more. Rats were not divided into optimal or suboptimal groups prior to neurochemical analysis.

Results: Disulfiram administered 2 h, but not 30 min, before the task dose-dependently improved choice behavior in the rats with an initial disadvantageous "gambling-like" strategy, while having no effect on the rats employing an advantageous strategy. The behavioral effects of disulfiram were associated with increased striatal dopamine and decreased striatal norepinephrine.

Conclusions: These findings suggest that combined actions on dopamine and norepinephrine may be a useful treatment for gambling disorders.

Citing Articles

Neurotransmitters crosstalk and regulation in the reward circuit of subjects with behavioral addiction.

Peng Z, Jia Q, Mao J, Luo X, Huang A, Zheng H Front Psychiatry. 2025; 15:1439727.

PMID: 39876994 PMC: 11773674. DOI: 10.3389/fpsyt.2024.1439727.

Understanding Individual Subject Differences through Large Behavioral Datasets: Analytical and Statistical Considerations.

Frankot M, Young M, Vonder Haar C Perspect Behav Sci. 2024; 47(1):225-250.

PMID: 38660505 PMC: 11035513. DOI: 10.1007/s40614-023-00388-9.

Sex-specific decision-making impairments and striatal dopaminergic changes after binge drinking history in rats.

Sauton P, Jeanblanc J, Benzerouk F, Gierski F, Naassila M Front Pharmacol. 2023; 14:1076465.

PMID: 36726581 PMC: 9885167. DOI: 10.3389/fphar.2023.1076465.

On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence.

Paredes-Ruiz K, Chavira-Ramos K, Orozco-Morales M, Karasu C, Tinkov A, Aschner M Neurotox Res. 2021; 39(6):2072-2097.

PMID: 34741755 DOI: 10.1007/s12640-021-00424-z.

Efficacy of pharmacotherapeutics for patients comorbid with alcohol use disorders and depressive symptoms-A bayesian network meta-analysis.

Li J, Wang H, Li M, Shen Q, Li X, Rong X CNS Neurosci Ther. 2020; 26(11):1185-1197.

PMID: 32686291 PMC: 7564195. DOI: 10.1111/cns.13437.

References

Di Ciano P, Pushparaj A, Kim A, Hatch J, Masood T, Ramzi A . The Impact of Selective Dopamine D2, D3 and D4 Ligands on the Rat Gambling Task. PLoS One. 2015; 10(9):e0136267. PMC: 4564230. DOI: 10.1371/journal.pone.0136267. View

Roy A, Adinoff B, Roehrich L, Lamparski D, Custer R, Lorenz V . Pathological gambling. A psychobiological study. Arch Gen Psychiatry. 1988; 45(4):369-73. DOI: 10.1001/archpsyc.1988.01800280085011. View

Colombo G, Maccioni P, Vargiolu D, Loi B, Lobina C, Zaru A . The dopamine β-hydroxylase inhibitor, nepicastat, reduces different alcohol-related behaviors in rats. Alcohol Clin Exp Res. 2014; 38(9):2345-53. DOI: 10.1111/acer.12520. View

Wee S, Mandyam C, Lekic D, Koob G . Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access. Eur Neuropsychopharmacol. 2007; 18(4):303-11. PMC: 2376122. DOI: 10.1016/j.euroneuro.2007.08.003. View

Song C, Fan X, Exeter C, Hess E, Jinnah H . Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia. Neurobiol Dis. 2012; 48(1):66-78. PMC: 3498628. DOI: 10.1016/j.nbd.2012.05.009. View

Le Foll B, Wilson A, Graff A, Boileau I, Di Ciano P . Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development. Front Pharmacol. 2014; 5:161. PMC: 4090596. DOI: 10.3389/fphar.2014.00161. View

Hart B, FAIMAN M . In vivo pharmacodynamic studies of the disulfiram metabolite S-methyl N,N-diethylthiolcarbamate sulfoxide: inhibition of liver aldehyde dehydrogenase. Alcohol Clin Exp Res. 1994; 18(2):340-5. DOI: 10.1111/j.1530-0277.1994.tb00023.x. View

Sofuoglu M, Kosten T . Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opin Emerg Drugs. 2006; 11(1):91-8. DOI: 10.1517/14728214.11.1.91. View

Mutschler J, Buhler M, Grosshans M, Diehl A, Mann K, Kiefer F . Disulfiram, an option for the treatment of pathological gambling?. Alcohol Alcohol. 2010; 45(2):214-6. DOI: 10.1093/alcalc/agp093. View

10.

Winefield R, Heemskerk A, Kaul S, Williams T, Caspers M, Prisinzano T . N-acetyl-S-(N,N-diethylcarbamoyl) cysteine in rat nucleus accumbens, medial prefrontal cortex, and in rat and human plasma after disulfiram administration. J Pharm Biomed Anal. 2015; 107:518-25. PMC: 4410022. DOI: 10.1016/j.jpba.2015.01.036. View

11.

George T, Chawarski M, Pakes J, Carroll K, Kosten T, Schottenfeld R . Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol Psychiatry. 2000; 47(12):1080-6. DOI: 10.1016/s0006-3223(99)00310-8. View

12.

Kodaira M, Iwadare Y, Ushijima H, Oiji A, Kato M, Sugiyama N . Poor performance on the Iowa gambling task in children with obsessive-compulsive disorder. Ann Gen Psychiatry. 2012; 11(1):25. PMC: 3508952. DOI: 10.1186/1744-859X-11-25. View

13.

Muller C, Banas R, Heinz A, Hein J . Treatment of pathological gambling with disulfiram: a report of 2 cases. Pharmacopsychiatry. 2011; 44(2):81-3. DOI: 10.1055/s-0031-1271683. View

14.

Biernacki K, McLennan S, Terrett G, Labuschagne I, Rendell P . Decision-making ability in current and past users of opiates: A meta-analysis. Neurosci Biobehav Rev. 2016; 71:342-351. DOI: 10.1016/j.neubiorev.2016.09.011. View

15.

Meyer G, Schwertfeger J, Exton M, Janssen O, Knapp W, Stadler M . Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology. 2004; 29(10):1272-80. DOI: 10.1016/j.psyneuen.2004.03.005. View

16.

Winstanley C, Cocker P, Rogers R . Dopamine modulates reward expectancy during performance of a slot machine task in rats: evidence for a 'near-miss' effect. Neuropsychopharmacology. 2011; 36(5):913-25. PMC: 3077261. DOI: 10.1038/npp.2010.230. View

17.

Zeeb F, Robbins T, Winstanley C . Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology. 2009; 34(10):2329-43. DOI: 10.1038/npp.2009.62. View

18.

Forget B, Hamon M, Thiebot M . Involvement of alpha1-adrenoceptors in conditioned place preference supported by nicotine in rats. Psychopharmacology (Berl). 2009; 205(3):503-15. DOI: 10.1007/s00213-009-1559-7. View

19.

Carroll K, Fenton L, Ball S, Nich C, Frankforter T, Shi J . Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry. 2004; 61(3):264-72. PMC: 3675448. DOI: 10.1001/archpsyc.61.3.264. View

20.

Robbins T . The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl). 2002; 163(3-4):362-80. DOI: 10.1007/s00213-002-1154-7. View